1. HBW Insight
  2. >>Wellness
  3. >>Policy & Regulation
  4. >>Recalls

US COVID-19 Warnings Continue Climbing, Violative Products Reach Recall Records

 
• By Malcolm Spicer

Additional products listed in FDA recall records update include Similac Pro-Advance Infant Formula filled with water, a lidocaine patch linked to potentially deficient manufacturing quality controls and two scents of PS Primer Water that may be contaminated. Number of hand sanitizer products exported from to the US and found containing methanol also continues to climb.

"Charlotte, NC / USA - April 9 2020: Billboard promoting a COVID-19 Fraud hotline for those who may be victims of fraudulent activity during the Corona Virus pandemic"

US regulatory agencies continue identifying OTC products, including at-home test kits, sold with fraudulent claims of detecting, preventing or treating COVID-19 as the Food and Drug Administration adds the first listing about a related product to its recall records.

Additional health, beauty and wellness products listed in the FDA’s 22 July recall records update include Similac Pro-Advance Infant Formula filled with water, a lidocaine patch linked to potentially deficient manufacturing quality controls and two

Meanwhile, the number of consumer hand sanitizer products exported from to the US and found containing methanol

More from Recalls

Old Problem Of Drugs In Supplements Welcomes US FDA’s Acting Food Chief To New Program

 
• By Malcolm Spicer

Kyle Diamantas was a partner with the Jones Day firm when he was tabbed as acting deputy commissioner to lead the FDA’s Human Foods Program, established in the agency’s reorganization which became effective in October.

Reporting Problems To US FDA Simplified After Delayed Response To Formula Plant Complaint

 
• By Malcolm Spicer

Streamlined process for reporting problems is key piece of “unified Human Foods Program” which officially launched on 1 October, as Commissioner Robert Califf says, “a new model for field operations and other modernization efforts.”

US Formula Market Astir With Changes As Congress Stirs Tighter Product Quality Regulations

 
• By Malcolm Spicer

Brands also making market moves as lawmakers consider legislation instructing Transportation Security Administration to provide guidance to minimize risk for contamination of baby formula and related pediatric nutritional products.

Different Name, Same Contamination, Recall Problems For US Homeopathic Nasal Spray Firm

 
• By Malcolm Spicer

Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.

More from Policy & Regulation

Digital Services Deliver Hemp, States Deliver Regulation With Congress Yet To Act

 
• By Malcolm Spicer

Four months into session, no bills have been introduced in Congress to authorize FDA to establish a regulatory pathway for the lawful use of hemp ingredients in products other than drugs or propose some other solution to the federal conundrum present since lawmakers in 2018 de-scheduled hemp.

Little Industry Opposition To FDA Plan To Remove Synthetic Dyes, Or Agreement They’re Unsafe

 
• By Malcolm Spicer

Dyes and colors which FDA says industries agree should no longer be used aren’t unsafe and are currently used only with the agency’s approval, industry stakeholders say. Center for Science in the Public Interest says the dyes are used “in tens of thousands of foods and beverages that are commonly consumed here in the United States.”

Bayer Study: Self-Care Is Hardest For Those Who Need It Most

 
• By David Ridley

Being poor makes it more likely that you will suffer from self-treatable health conditions but it also means you will find it harder to take advantage of self-care solutions, finds a recently-published study by Bayer Consumer Health and IQVIA.